The transcription factor Foxp3 has an indispensable role in establishing stable transcriptional and functional programs of regulatory T cells (T reg cells). Loss of Foxp3 expression in mature T reg cells results in a failure of suppressor function, yet the molecular mechanisms that ensure steady, heritable Foxp3 expression in the T reg cell lineage remain unknown. Using T reg cell-specific gene targeting, we found that complexes of the transcription factors Runx and CBF were required for maintenance of Foxp3 mRNA and protein expression in T reg cells. Consequently, mice lacking CBF exclusively in the T reg cell lineage had a moderate lymphoproliferative syndrome. Thus, Runx-CBF complexes maintain stable high expression of Foxp3 and serve as an essential determinant of T reg cell lineage stability.
A r t i c l e s
The regulatory T cell (T reg cell) lineage is indispensable for suppressing autoimmunity and preventing overexuberant responses to pathogens 1 . The X chromosome-encoded transcription factor Foxp3 (A002750) is a lineage-specification factor required for T reg cell differentiation and function [2] [3] [4] . Furthermore, continuous expression of Foxp3 in mature T reg cells is required for the maintenance of suppressor function and of the Foxp3-dependent transcriptional program 5 . Genomewide analysis of Foxp3-binding sites coupled to gene-expression profiling suggest that Foxp3 can act as both a transcriptional activator and repressor [6] [7] [8] . For example, binding of Foxp3 to the promoters and 5′ regulatory regions of Ctla4 (encoding the immunomodulatory receptor CTLA-4) and Il2ra (encoding interleukin 2 receptor-α (IL-2Rα); also called CD25) results in their activation, whereas binding of Foxp3 to the Il2 and Il7ra promoters facilitates repression of these genes. The dual activity of Foxp3 defines characteristic features of T reg cells, which have high expression of CTLA-4 and CD25 but low expression of IL-7R and lack IL-2 production 6, 7 .
Although the identity of Foxp3 target genes and understanding of their roles in T reg cell biology have began to emerge, the mechanisms that regulate expression of the Foxp3 gene itself remain poorly understood. Many sequence-specific transcription factors, including STAT5, NFAT, CREB, Smad3 and NF-κB, have been linked to the transcriptional regulation of Foxp3 expression, yet questions remain about their redundancy and direct or indirect effect on Foxp3 transcriptional activation versus survival of T reg cells or their precursors [9] [10] [11] [12] . For example, STAT5 is proposed to be essential for Foxp3 induction, yet forced expression of the antiapoptotic molecule Bcl-2 in T reg cell precursors restores Foxp3 expression in the absence of STAT5 (refs. 9,10 and S. Malin and M. Busslinger, personal communication). Furthermore, the molecular mechanisms by which Foxp3 controls gene expression in T reg cells seem to be complex. Interactions of Foxp3 with other sequence-specific transcription factors have been proposed to be essential for establishment of the Foxp3-dependent transcriptional program. In this context, Foxp3 can interact with NFAT; these two proteins act together to activate Ctla4 and Il2ra and antagonize Il2 expression dependent on NFAT and the transcription factor AP-1 (ref. 13 ). The interaction between Foxp3 and the RUNT domaincontaining transcription factor Runx1 (A000523; also called CBFα2) has been suggested to be critical for T reg cell function. Mutations in Foxp3 that abrogate its interaction with Runx1 result in loss of Foxp3 function. Unlike wild-type Foxp3 protein, the mutant form of Foxp3 is unable to repress Il2 production or activate Il2ra or Ctla4 when ectopically expressed in CD4 + CD25 -T cells 14 . Using a proteomics approach, we also found that Runx1 and its cofactor CBFβ (A000524) are prominently represented among the binding partners of Foxp3 (D.R. et al., unpublished observations).
The transcriptional activity of Runx proteins is dependent on the formation of heterodimers with CBFβ 15 . CBFβ stabilizes Runx protein-DNA interactions and prevents ubiquitin-mediated Runx degradation, thus serving as an indispensable component of Runx transcriptional complexes 16, 17 . The three known Runx factors (Runx1-Runx3) are broadly expressed in hematopoietic cells, including T cells, where they have important roles at various stages of differentiation 18 . Expression of T cell antigen receptor genes requires Runx1, which also acts as a transcriptional repressor of the Cd4 locus in CD4 -CD8thymocytes [19] [20] [21] [22] [23] . Runx3 is expressed in and represses Cd4 expression in CD8 + T cells 23 . Runx3 has also been suggested to interact with the T helper type 1 (T H 1) lineage-specification factor T-bet and to facilitate activation of the gene encoding interferon-γ and repression of Il4 in T H 1 cells 24 .
The documented importance of Runx in cell fate 'decisions' during T cell differentiation and Runx interactions with Foxp3 prompted us to investigate the role of Runx proteins in T reg cell biology in vivo using a genetic approach. We took advantage of the fact that transcriptional activity of all the three Runx proteins is dependent on CBFβ and ablation of Cbfb therefore results in complete loss of Runx function. To address Runx protein function specifically in the T reg cell lineage, we induced deletion of a loxP-flanked Cbfb allele in T reg cells by crossing the previously described Cbfb fl mice (which have a loxP-flanked Cbfb allele) with Foxp3 YFP-Cre mice (which express a fusion protein of yellow fluorescent protein and Cre recombinase (YFP-Cre) under the control of Foxp3 regulatory elements) 25, 26 . Unexpectedly, we found that Runx factors were largely dispensable for the expression of Foxp3 target genes and T reg cell suppressor function. However, Runx protein function was critical for maintaining expression the Foxp3 gene itself. Thus, Runx proteins are essential for maintaining high Foxp3 expression, which ensures T reg cell lineage identity.
RESULTS

Lymphoproliferation in Cbfb fl/fl Foxp3 YFP-Cre mice
To determine the functional consequence of ablating Runx activity in T reg cells, we crossed Cbfb fl mice with Foxp3 YFP-Cre mice 25, 26 . We confirmed efficient Cre-mediated deletion of the Cbfb fl allele by PCR analysis of genomic DNA isolated from sorted YFP-Foxp3 + T reg cells from Cbfb fl/+ Foxp3 YFP-Cre and Cbfb fl/fl Foxp3 YFP-Cre mice and demonstrated subsequent lower expression of Cbfb mRNA by realtime PCR analysis of RNA isolated from these cells ( Supplementary  Fig. 1a-d) . Furthermore, immunoblot analysis confirmed the absence of CBFβ protein only in sorted T reg cells derived from Cbfb fl/fl Foxp3 YFP-Cre mice (Supplementary Fig. 1e ). Analysis of DNA, RNA and protein expression indicated that deletion of the Cbfb fl allele was limited to CD4 + YFP-Foxp3 + T reg cells and did not occur in the CD4 + YFP -'non-T reg ' cells.
Cbfb fl/fl Foxp3 YFP-Cre mice were born at the expected mendelian ratios and showed no clinical signs of autoimmunity until 12-14 weeks of age. Nevertheless, examination of the secondary lymphoid organs of 5-to 8-week-old mutant mice showed lymphadenopathy and splenomegaly and T cell activation ( Fig. 1) . The lymphoproliferative syndrome in these mice was relatively minor compared with that of Foxp3-deficient mice or mice that express the diphtheria toxin receptor under control of the Foxp3 promoter, subjected to ablation of T reg cells by treatment with diphtheria toxin 2, 27 . Examination of tissue pathology showed moderate to considerable lymphohistiocytic and occasionally plasmacytic inflammation in the affected tissues of the diseased mice ( Fig. 2) . Notably, the lungs had multifocal perivascular and peribronchiolar lymphohistiocytic pneumonitis and arteritis with considerable proliferative arteriopathy and bronchiolar goblet cell hyperplasia ( Fig. 2) .
Analysis of the relative sizes of thymocyte subsets as well as lymphoid and myeloid cell subsets, including CD4 + and CD8 + T cells, B cells, natural killer cells, dendritic cells and macrophages in the spleen and lymph nodes did not show substantial differences between mutant and wild-type mice ( Fig. 1c and Supplementary Fig. 2) . To assess the extent of activation of CD4 + Foxp3 -T cells in these mice, we analyzed the expression of a panel of known activation markers, including CD25, GITR, ICOS, CTLA-4 and CD62L, and found a slightly greater proportion of activated T cells in Cbfb fl/fl Foxp3 YFP-Cre mice (Fig. 1d) . Likewise, the number of proliferating cells, identified on the basis of Ki67 expression, was only slightly higher ( Fig. 1d) , whereas changes in T H 1 and T H 2 cytokine production were insubstantial in mice with CBFβ-deficient T reg cells (data not shown). Thus, the mild dysregulation of T cell responses in the 
CBF controls Foxp3 expression
To directly assess the functional potential of T reg cells in Cbfb fl/fl Foxp3 YFP-Cre mice, we first examined Foxp3 expression in these cells, as large amounts of Foxp3 are required for T reg cell suppressor function 7, 28, 29 . Unexpectedly, intracellular Foxp3 staining combined with flow cytometry showed that peripheral T reg cells lacking CBFβ had much less Foxp3 protein ( Fig. 3a) .
They had similarly less YFP-Cre fusion protein than did CBFβ-sufficient T reg cells ( Supplementary Fig. 3 ), which suggested that downregulation of Foxp3 expression occurred at a transcriptional level. Indeed, real-time PCR analysis of RNA isolated from sorted CD4 + YFP + T reg cells showed much less Foxp3 mRNA in the absence of CBFβ (Fig. 3b) . In contrast to Foxp3 in peripheral T reg cells, the amount of Foxp3 protein was similar in Foxp3 + thymocytes from Cbfb fl/fl Foxp3 YFP-Cre and Cbfb fl/+ Foxp3 YFP-Cre mice, probably because of 'carryover' of CBFβ protein from Foxp3precursor thymocytes. In agreement with that idea, Foxp3 expression in CD4 + single-positive thymocytes from Cbfb fl/fl mice with Cre expression driven by the CD4 promoter (Cbfb fl/fl CD4-Cre + mice) was diminished, although to a lesser extent than in the periphery ( Supplementary  Fig. 4a,b) . We found a similar cell-intrinsic effect of CBFβ deficiency, characterized by much lower Foxp3 expression mainly in the periphery, after transfer of CD45.2 + Cbfb fl/fl CD4-Cre + and CD45.1 + C57BL/6 bone marrow together into recipient mice deficient in the RAG recombinase ( Supplementary Fig. 4b ).
Although it was formally possible that selective outgrowth or survival of Foxp3 lo cells in the absence of CBFβ accounted for the observed lower Foxp3 expression in the CBFβ-deficient T reg cell population, we found that Foxp3 hi cells lacking CBFβ divided more than their Foxp3 lo counterparts ( Supplementary Fig. 5 ), in agreement with an earlier finding that high Foxp3 expression
confers proliferative potential to T reg cells 7 . Furthermore, CBFβ-deficient Foxp3 hi T reg cells did not show more apoptosis than Foxp3 lo cells (data not shown). Together these results indicate that Runx-CBFβ complexes control Foxp3 expression in T reg cells.
To conclusively demonstrate that the smaller amount of Foxp3 in Cbfb fl/fl Foxp3 YFP-Cre mice was due to the inactivation of the Runx-CBFβ complexes and not to an as-yet-unknown Runx-independent function of CBFβ, we generated Runx1 fl/fl Foxp3 YFP-Cre mice in which Runx1, which was more prominently expressed than Runx3 in T reg cells, was ablated after Cre-mediated deletion of a conditional Runx1 fl allele ( Supplementary Fig. 6a ). Like Cbfb fl/fl Foxp3 YFP-Cre mice, Runx1 fl/fl Foxp3 YFP-Cre mice had substantially less Foxp3 in peripheral T reg cells ( Supplementary Fig. 6b ). Additionally, Runx1deficient Foxp3 + thymocytes also had slightly less Foxp3 on a 'per-cell' basis, albeit to a lesser extent than that in peripheral T reg cells ( Supplementary Fig. 6b) . The difference in Foxp3 amounts in Runx1and CBFβ-deficient Foxp3 + thymocytes from Cbfb fl/fl Foxp3 YFP-Cre and Runx1 fl/fl Foxp3 YFP-Cre mice may be attributed to a shorter half-life and lower abundance of Runx1 relative to that of CBFβ.
The CBFβ-deficient T reg cell population in Cbfb fl/fl Foxp3 YFP-Cre mice, but not that in healthy littermate Cbfb fl/+ Foxp3 YFP-Cre mice, had higher proportions of GITR hi , ICOS hi and Ki67 + cells, indicative of heightened activation and proliferation probably driven by proliferation and activation of non-T reg cells ( Fig. 3c and data not shown). CBFβ-deficient T reg cells suppressed the proliferative responses of CD4 + Foxp3 -T cells in vitro similarly to their CBFβsufficient counterparts (Fig. 3d) . Thus, in agreement with the slowly progressing immune lesions and moderate lymphoproliferative syndrome of Cbfb fl/fl Foxp3 YFP-Cre mice, the CBFβ-deficient T reg cell population as a whole did maintain its suppressor capacity, probably because of the presence of Foxp3 hi T reg cells recently emigrated from the thymus.
To assess the competitive fitness of CBFβ-deficient T reg cells in the absence of inflammation, we examined relative sizes of CBFβsufficient and CBFβ-deficient T reg cell subsets in healthy heterozygous Cbfb fl/fl Foxp3 YFP-Cre/+ and Cbfb fl/+ Foxp3 YFP-Cre/+ female mice. The proportion of peripheral YFP-Cre + T reg cells was markedly lower in Cbfb fl/fl Foxp3 YFP-Cre/+ mice than in Cbfb fl/+ Foxp3 YFP-Cre/+ mice (Fig. 3e,f) . In these disease-free mice, CBFβ-deficient YFP-Cre + T reg cells also had much lower expression of Foxp3 on a 'per-cell' basis than did their CBFβ-sufficient counterparts, in agreement with findings obtained with diseased Cbfb fl/fl Foxp3 YFP-Cre mice. Thus, CBFβ deficiency in T reg cells results in smaller amounts of Foxp3, which probably leads to an impaired suppressive capacity and diminished competitive fitness in the presence of CBFβ-sufficient T reg cells.
Cbf is critical for maintaining Foxp3 expression in T reg cells
Although the analysis of T reg cells from Runx1 fl/fl Foxp3 YFP-Cre and Cbfb fl/fl Foxp3 YFP-Cre mice made it evident that the Runx-CBFβ deficiency impairs Foxp3 expression, the extent to which Foxp3 expression was affected in these mice was difficult to assess because of the aforementioned continuous thymic output. To directly assess the potential loss of Foxp3 expression in a cohort of peripheral T reg cells lacking CBFβ, we sorted CD45.2 + CD4 + YFP hi cells from Cbfb fl/fl Foxp3 YFP-Cre mice or Cbfb fl/+ Foxp3 YFP-Cre mice, mixed them with CD4 + effector T cells from CD45.1 + Foxp3mice and adoptively transferred the mixture into Rag2 -/recipients. Flow cytometry of the transferred cells demonstrated that in addition to having less Foxp3, the CBFβdeficient T reg population showed a more pronounced loss of Foxp3 with considerably faster kinetics than did the CBFβ-sufficient T reg cell population ( Fig. 4) . Thus, Runx-CBFβ regulates both the amount and stability of Foxp3 expression in T reg cells.
Runx-CBF binds to the Foxp3 locus
In addition to having a conserved promoter region, the Foxp3 locus contains two proximal conserved noncoding sequence elements (CNS1 and CNS2) downstream of the transcription start site 11, 12 . Both CNS1, which contains a Smad-NFAT response element, and CNS2, which contains CREB-ATF-and STAT5-binding sites, have been proposed to act as enhancers important for Foxp3 induction in the thymus and periphery 11, 12 . To determine whether Runx-CBFβ complexes bind to the Foxp3 promoter and conserved noncoding sequence elements in vivo, we did chromatin immunoprecipitation (ChIP) analysis of CBFβ precipitated from nuclear lysates isolated from wild-type T reg cells. We found marked enrichment of CBFβ bound to CNS2. In addition, we reproducibly found enrichment of CBFβ at the Foxp3 promoter despite a very high background in the control ChIP with immunoglobulin G (IgG; Fig. 5 ). We used the enhancer of the gene encoding T cell antigen receptor β-chain (Tcrb), known to bind Runx1-CBFβ, as a positive control, and the promoter of the gene encoding actin as a negative contol, in these experiments 20 . 
A r t i c l e s
To test whether binding of Runx-CBFβ to the Foxp3 promoter and CNS2 directly facilitated Foxp3 transcription, we did luciferase reporter assays with primary T reg cells and the EL4 mouse lymphoma T cell line. We assessed the role of putative Runx-binding sites in the promoter and CNS2 in the direct enhancement of Foxp3 transcription mediated by these elements. In agreement with published reports 11 , the minimal Foxp3 promoter did not show measurable activity in the reporter assay ( Supplementary Fig. 7a,b) . Although nonchromatinized DNA constructs containing the minimal Foxp3 promoter and CNS1 or CNS2 had a stronger luciferase signal in the presence of phorbol 12-myristate 13-acetate and ionomycin with and without transforming growth factor-β, mutations of the predicted Runx-binding sites had no measurable effect on CNS-mediated enhancement of Foxp3 promoter activity in EL4 cells or purified CBFβ-sufficient T reg cells (Supplementary Fig. 7c-e) . Similarly, the CNS2-containing reporter drove similar luciferase expression in CBFβ-deficient and CBFβ-sufficient T reg cells (Supplementary Fig. 7e) . These results suggested that Runx-CBFβ complexes might regulate Foxp3 expression through epigenetic changes at the Foxp3 locus; this type of regulation could not be accounted for in a reporter assay. In support of this idea, we detected much lower abundance of permissive trimethylation modifications of histone H3 at lysine 4 (H3-K4me3) at the Foxp3 promoter and concomitant widespread increase in inhibitory histone H3-K9me3 modifications at the 5′ end of the Foxp3 locus ( Fig. 6) in CBFβdeficient T reg cells. In contrast to augmented H3-K9me3 inhibitory marks, the distribution of another prototypic nonpermissive histone modification, H3-K27me3, across the Foxp3 locus was unchanged in CBFβ-deficient T reg cells (Fig. 6) . Thus, it seems likely that Runx-CBFβ complexes impart permissive epigenetic modifications and oppose certain inhibitory modifications on the Foxp3 locus.
Competent suppressor function of CBF-deficient cells
Lower and unstable Foxp3 expression may result in attenuated in vivo T reg cell suppressor function, which might have contributed to the lymphoproliferative syndrome of Cbfb fl/fl Foxp3 YFP-Cre mice. However, it was also possible that Runx-CBFβ-Foxp3 complexes contributed to T reg functionality by acting together to regulate the T reg cell gene expression 'signature' . To directly distinguish between those two possibilities, we examined expression of the characteristic T reg cell surface molecules CTLA-4, CD25 and GITR after 'forced' Foxp3 expression in CBFβsufficient or CBFβ-deficient non-T reg CD4 + cells (Fig. 7) . Published studies have shown that retroviral transduction of CD25 -CD4 + T cells with a Foxp3-expressing retrovirus confers a characteristic T reg cell surface phenotype and suppressor function on non-T reg cells 2,3 . It is noteworthy that the amount of Foxp3 expression in retrovirally transduced cells in those experiments is similar to or lower than that observed in T reg cells 2, 3 . We used the previously described 2 retroviral bi-cistronic vector to express both Foxp3 and green fluorescent protein (GFP) or GFP alone in activated CD25 -CD4 + T cells from Cbfb fl/fl CD4-Cre + mice or Cbfb +/+ CD4-Cre + littermate control mice and examined the aforementioned surface markers and in vitro suppressor activity of Foxp3 + GFP + and control GFP + T cells purified by flow cytometry. Because the retroviral vector expressing Foxp3 cDNA was devoid of the endogenous Foxp3 regulatory elements that serve as targets of Runx-CBFβ transcriptional complexes, we found similar Foxp3 expression in transduced CBFβ-deficient and CBFβ-sufficient T cells (Fig. 7a) . Furthermore, GITR, CTLA-4 and CD25 were present in similar amounts in CBFβ-deficient and CBFβ-sufficient Foxp3-expressing T cells (Fig. 7a) , and these cells showed similar suppressor activity in vitro (Fig. 7b) . In contrast, the GFP vector-transduced CBFβ-deficient and CBFβ-sufficient T cells demonstrated no suppressive ability. Instead, they showed enhanced proliferation relative to that of freshly isolated responder T cells (Fig. 7c) , presumably because of their prior activation during the retroviral transduction.
To assess in vivo suppressor capacity of T reg cells lacking CBFβ but transduced with a Foxp3-encoding retrovirus, we isolated Foxp3 + T reg cells from Cbfb fl/fl Foxp3 YFP-Cre mice or control Cbfb fl/+ Foxp3 YFP-Cre mice and transduced them with another bi-cistronic retroviral vector containing the Foxp3 coding sequence followed by an internal ribosomal entry site-driven 'tailless' human CD2 reporter. As a control, we transduced cells with the retroviral vector containing the internal ribosomal entry site-driven 'tailless' human CD2 reporter but lacking the Foxp3 insert. We sorted transduced T reg cells by flow cytometry and transferred them together with effector T cells isolated from Foxp3mice into Tcrb -/-Tcrd -/recipient mice. Transfer of effector Foxp3 -T cells alone led to a characteristic systemic lymphoproliferative immune-mediated syndrome associated with severe weight loss, lymphadenopathy, splenomegaly and more production of T H 1 and T H 2 cytokines ( Fig. 7d and Supplementary Fig. 8 A r t i c l e s of Foxp3-or control vector-transduced control CBFβ-sufficient T reg cells or Foxp3-transduced CBFβ-deficient T reg cells led to an essentially complete 'rescue' of the lymphoproliferative syndrome in the recipient mice. In agreement with relatively mild late-onset autoimmune lesions in unmanipulated Cbfb fl/fl Fox3p YFP-Cre mice, CBFβdeficient T reg cells transduced with the control vector showed only a mild impairment in suppressor function, reflected in the partial 'rescue' of recipient mice from the weight loss (Fig. 7d) . It is noteworthy that both Foxp3-and control vector-transduced CBFβ-deficient T reg cells seemed somewhat less efficient at limiting IL-4 production by effector T cells than did control CBFβ-sufficient T reg cells ( Supplementary  Fig. 8e ). In agreement with the weight-loss data, the small inflammation foci in the liver, skin and lungs in recipient mice given effector T cells and control vector-transduced CBFβ-deficient T reg cells were absent in the presence of Foxp3-transduced CBFβ-deficient or CBFβ-sufficient T reg cells or control vector-transduced CBFβ-sufficient T reg cells (Supplementary Fig. 8f) . Thus, Foxp3 + T reg cells in the absence of CBFβ show only modestly lower in vivo suppressor function, and ectopic Foxp3 expression largely restores this function. The last results are in agreement with unimpeded in vitro suppression ability of Foxp3-transduced CBFβ-deficient CD4 + T cells (Fig. 7b) . These results suggest that Foxp3 is able to confer T reg cell-specific gene expression and suppressive ability in the absence of functional Runx-CBFβ complexes and that the moderate decrease in the suppressor function of T reg cells lacking CBFβ is due mainly to progressively diminishing Foxp3 expression.
DISCUSSION
Our studies suggest that in T reg cells, Runx-CBFβ activity is required for maintaining Foxp3 expression. The lack of clinical signs of an overt autoimmune phenotype in Cbfb fl/fl Foxp3 YFP-Cre mice up to 8-10 months of age was in contrast to the very short 3-to 5-week lifespan of mice lacking Foxp3. Consistent with the late occurrence of gross clinical manifestations, the lymphadenopathy, splenomegaly and activation of CD4 + Foxp3effector T cells in Cbfb fl/fl Foxp3 YFP-Cre mice were relatively mild. It is notable, however, that the only pronounced tissue pathology in mice with CBFβ-deficient T reg cells was a substantial pulmonary arteriopathy similar to that in two published studies that proposed involvement of T reg cells in the pathogenesis of this disease 30, 31 . Notably, human patients with lupus, who, like aged Cbfb fl/fl Foxp3 YFP-Cre mice, have a smaller T reg cell subset, often develop severe angioproliferative pulmonary hypertension with analogous histopathological lesions 32 . Except for the lung arteriopathy, the immune-mediated inflammation in other tissues was far less severe and its progression was much slower than that in mice with complete loss of T reg cell function or lack of T reg cells 2, 27 . Of note, ablation of CBFβ in CD4 + T cells in Cbfb fl/fl CD4-Cre + -mice results in asthma-related symptoms due to an enhanced T H 2 response presumably due to impaired silencing of the Il4 locus in T H 1 cells 25 . Consistent with those results, Runx-CBFβ activity was probably not a prerequisite for T reg function, as ectopic expression of Foxp3 in CBFβ-deficient CD4 + CD25 -T cells derived from Cbfb fl/fl CD4-Cre + mice resulted in a prototypical pattern of Foxp3 target-gene expression and conferred suppressive ability on these cells. Therefore, it seems that in T reg cells, the main function of Runx-CBFβ is to regulate the amount and stability of Foxp3 expression.
Runx-CBFβ nuclear factors may influence Foxp3 expression in three different yet not mutually exclusive ways. They can bind to Foxp3 and facilitate its transcription, or regulate the locus by modifying the chromatin structure and keeping it in an open configuration. In addition, the effect of Runx-CBFβ on Foxp3 expression in T reg cells can be indirect, if a known or unknown regulator of Foxp3 is under the control of Runx proteins. Our observation that in T reg cells, CBFβ occupied the Foxp3 promoter and CNS2 supports the first two possibilities. However, the presence or absence of Runx-CBFβ complexes in primary T reg cells had little if any effect on the expression of a luciferase reporter construct containing Foxp3 promoter and CNS2 sequences, which suggests the possibility that Runx-CBFβ complexes maintain Foxp3 expression in T reg cells through epigenetic modifications of the Foxp3 locus. Indeed, ablation of CBFβ in T reg cells was associated with much lower abundance of permissive H3-K4me3 modifications immediately downstream of and at the Foxp3 promoter and selectively greater abundance of nonpermissive H3-K9me3 modifications, but not H3-K27me3 modifications, at the Foxp3 locus. Thus, these results are consistent with the idea that Runx-CBFβ complexes promote the active state of the Foxp3 locus by an epigenetic mechanism. Further evidence in favor of this possibility comes from our finding that mice lacking CNS2 show a progressive loss of Foxp3 expression in the progeny of dividing Foxp3 + cells similar to that in Cbfb fl/fl Foxp3 YFP-Cre mice (Y. Zheng et al., unpublished observations) .
In contrast to results obtained with peripheral Foxp3 + T cells, Cre-mediated deletion of the Cbfb fl allele in Foxp3-expressing cells did not result in lower Foxp3 expression in the thymus. This finding could suggest that Runx-CBFβ-mediated regulation of Foxp3 expression is dispensable in the thymus. However, another possible explanation is highlighted by the documented 'carryover' of CBFβ protein 25 , which lingers in thymocytes long after deletion of the Cbfb allele. In this context, a study has shown that even after conditional CD4-Cre-mediated deletion of the Cbfb fl allele in CD4 + CD8 + thymocytes, CBFβ protein is readily detectable by immunoblot analysis in CD4 + CD8thymocytes but not in peripheral CD4 + CD8 -T cells 25 . Indeed, in our analysis of Cbfb fl/fl CD4-Cre + mice, we found that Foxp3 expression was lower in CD4 + single-positive thymocytes from Cbfb fl/fl CD4-Cre + mice than in those from Cbfb fl/fl Foxp3 YFP-Cre mice, presumably due to earlier deletion of the Cbfb fl allele in the former mice. Nevertheless, the extent of the decrease was less that than in the periphery. We found a similar cell-intrinsic effect of CBFβ deficiency, characterized by much lower Foxp3 expression mainly in the periphery after transfer of a mixture of Cbfb fl/fl CD4-Cre + and wildtype bone marrow into RAG-deficient recipients. Further support for the idea that CBFβ-Runx complexes are involved in regulating Foxp3 expression in the thymus came from our comparison of T reg cell-specific ablation of Runx1 or CBFβ. Although T reg cell-specific ablation of Runx1 or CBFβ resulted in a similar lower abundance of in Foxp3 in the peripheral cells, Runx1-deficient Foxp3 + thymocytes had much less Foxp3, probably because of faster turnover or smaller amounts of Runx1. Thus, our studies suggest that Runx-CBFβ complexes have a nonredundant role in the maintenance of Foxp3 expression both in the thymus and in the periphery.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Accession codes. UCSD-Nature Signaling Gateway (http://www. signaling-gateway.org): A002750, A000523 and A000524.
Note: Supplementary information is available on the Nature Immunology website.
